Back to Search
Start Over
Pinocembrin flavanone inhibits cell viability in PC-3 human prostate cancer by inducing cellular apoptosis, ROS production and cell cycle arrest
- Source :
- Acta Pharmaceutica, Vol 71, Iss 4, Pp 669-678 (2021), Acta Pharmaceutica, Volume 71, Issue 4
- Publication Year :
- 2021
- Publisher :
- Sciendo, 2021.
-
Abstract
- The main purpose of the present study was to evaluate the antitumor effects of pinocembrin in human prostate cancer cells (PC-3) along with investigating its effects on cell apoptosis, endogenous ROS production and cell cycle. MTT assay and clonogenic assays were used to study the effects on cell viability and cancer colony formation, respectively. Fluorescence microscopy along with Western blotting was used to study apoptotic effects induced by pinocembrin. Flow cytometry was used to study effects on ROS production and cell cycle phase distribution. Results indicated that pinocembrin promoted inhibition cell proliferation along with reducing cancer colony formation of PC-3 cells in a dose-dependent manner. Pinocembrin induced regulatory effects over expressions of caspase-3, caspase-9, Bax and Bcl-2, thereby promoting apoptotic cell death in PC-3 cells. It also led to the dose-dependent G0/G1 cell cycle arrest. In conclusion, pinocembrin exhibits strong anticancer effects in human prostate cancer cells mediated via apoptosis, endogenous ROS production and G0/G1 cell cycle arrest.
- Subjects :
- Cell cycle checkpoint
Pharmaceutical Science
Flavones
Human prostate
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
flavones
medicine
Viability assay
Pharmaceutical industry
030304 developmental biology
Pharmacology
chemistry.chemical_classification
0303 health sciences
Pinocembrin
pinocembrin
apoptosis
Cancer
General Medicine
medicine.disease
prostate cancer
chemistry
Apoptosis
cell cycle arrest
030220 oncology & carcinogenesis
Cancer research
HD9665-9675
prostrate cancer
Flavanone
Subjects
Details
- Language :
- English
- ISSN :
- 18469558 and 13300075
- Volume :
- 71
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Acta Pharmaceutica
- Accession number :
- edsair.doi.dedup.....f38cdb469a0fa315516d52d87a3955cd